Polianta Ltd Continues to Hold Position in Express Scripts Holding Company (ESRX)

Polianta Ltd held its stake in shares of Express Scripts Holding Company (NASDAQ:ESRX) during the second quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 14,900 shares of the company’s stock at the end of the second quarter. Polianta Ltd’s holdings in Express Scripts Holding were worth $951,000 at the end of the most recent reporting period.

A number of other hedge funds also recently made changes to their positions in ESRX. Dubuque Bank & Trust Co. increased its position in shares of Express Scripts Holding by 53.1% in the first quarter. Dubuque Bank & Trust Co. now owns 1,753 shares of the company’s stock worth $116,000 after buying an additional 608 shares in the last quarter. TrimTabs Asset Management LLC acquired a new position in shares of Express Scripts Holding during the first quarter worth approximately $121,000. Capital Analysts LLC increased its position in shares of Express Scripts Holding by 5.6% in the first quarter. Capital Analysts LLC now owns 1,877 shares of the company’s stock worth $124,000 after buying an additional 100 shares in the last quarter. IHT Wealth Management LLC increased its position in shares of Express Scripts Holding by 8.1% in the first quarter. IHT Wealth Management LLC now owns 1,944 shares of the company’s stock worth $128,000 after buying an additional 145 shares in the last quarter. Finally, FNY Partners Fund LP acquired a new position in shares of Express Scripts Holding during the first quarter worth approximately $138,000. Hedge funds and other institutional investors own 90.24% of the company’s stock.

Express Scripts Holding Company (ESRX) traded up 0.83% during midday trading on Wednesday, hitting $62.24. The stock had a trading volume of 792,868 shares. The stock has a market cap of $35.95 billion, a PE ratio of 10.80 and a beta of 0.90. The company’s 50 day moving average price is $62.51 and its 200-day moving average price is $64.30. Express Scripts Holding Company has a 52-week low of $57.80 and a 52-week high of $77.61.

Express Scripts Holding (NASDAQ:ESRX) last issued its earnings results on Tuesday, July 25th. The company reported $1.73 earnings per share for the quarter, beating the Zacks’ consensus estimate of $1.71 by $0.02. The business had revenue of $25.35 billion during the quarter, compared to analyst estimates of $25.52 billion. Express Scripts Holding had a return on equity of 25.58% and a net margin of 3.50%. Express Scripts Holding’s revenue was up .5% on a year-over-year basis. During the same period in the previous year, the company posted $1.57 EPS. Analysts forecast that Express Scripts Holding Company will post $6.99 EPS for the current fiscal year.

COPYRIGHT VIOLATION WARNING: This story was originally published by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this story on another publication, it was stolen and republished in violation of U.S. and international copyright & trademark laws. The correct version of this story can be read at https://sportsperspectives.com/2017/08/16/polianta-ltd-continues-to-hold-position-in-express-scripts-holding-company-esrx.html.

A number of equities analysts recently commented on the company. UBS AG set a $71.00 target price on Express Scripts Holding and gave the company a “hold” rating in a report on Tuesday, April 25th. BidaskClub downgraded Express Scripts Holding from a “sell” rating to a “strong sell” rating in a report on Friday, August 4th. Morgan Stanley upped their target price on Express Scripts Holding from $52.00 to $57.00 and gave the company an “underweight” rating in a report on Thursday, August 10th. Cowen and Company restated an “outperform” rating and set a $83.00 target price on shares of Express Scripts Holding in a report on Friday, June 9th. Finally, Evercore ISI decreased their target price on Express Scripts Holding from $68.50 to $59.00 and set an “in-line” rating for the company in a report on Wednesday, April 26th. Four research analysts have rated the stock with a sell rating, thirteen have issued a hold rating, five have assigned a buy rating and one has given a strong buy rating to the company. Express Scripts Holding currently has a consensus rating of “Hold” and an average price target of $71.17.

In other news, VP Phyllis S. Anderson sold 1,100 shares of the business’s stock in a transaction on Friday, May 19th. The stock was sold at an average price of $60.08, for a total value of $66,088.00. Following the completion of the transaction, the vice president now directly owns 11,108 shares of the company’s stock, valued at approximately $667,368.64. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. Insiders own 0.68% of the company’s stock.

Express Scripts Holding Company Profile

Express Scripts, Inc is a pharmacy benefit management (PBM) company in North America, offering a range of services to its clients, which include health insurers, third-party administrators, employers, union-sponsored benefit plans, workers’ compensation plans and government health programs. It operates in two segments: PBM and Emerging Markets (EM).

Want to see what other hedge funds are holding ESRX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Express Scripts Holding Company (NASDAQ:ESRX).

Institutional Ownership by Quarter for Express Scripts Holding (NASDAQ:ESRX)

Receive News & Ratings for Express Scripts Holding Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Express Scripts Holding Company and related companies with MarketBeat.com's FREE daily email newsletter.

Latest News

Leave a Reply